Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.33 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | TLR4 | O00206 | 1/20 | 0.31 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.30 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9479135 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL123151 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL693557 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL216035 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL8361882 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL20552191 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL6682662 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL5699292 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL1053630 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 | |
| SCHEMBL11552545 | 1.00 | KDM1A (0.48) | KDM1AMAPTHSD11B1HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1454 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344236-A | Separation method of benzene-cyclohexene-cyclohexane | 浙江恒逸石化研究院有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-20240217905-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2024-07-04 | — | — | US | claimed |
| CN-118271263-A | Recovery preparation method of dicyclohexyl ether | 岳阳昌德新材料有限公司 | 2024-07-02 | — | — | CN | claimed |
| EP-4352068-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-04-17 | — | — | EP | claimed |
| CN-117642409-A | Chromium-catalyzed alcohol production from hydrocarbons in the presence of oxygen | 切弗朗菲利浦化学公司 | 2024-03-01 | — | — | CN | claimed |
| US-20240043360-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2024-02-08 | — | — | US | claimed |
| US-11814563-B2 | Bioreachable chiral dopants for liquid crystal applications | ZYMERGEN INC. (US) | 2023-11-14 | — | — | US | claimed |
| US-20230203378-A1 | FORMULATIONS OF BIOREACHABLE DOPANTS FOR LIQUID CRYSTALS | KENT STATE UNIVERSITY | 2023-06-29 | — | — | US | claimed |
| WO-2022260947-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2022-12-15 | — | — | WO | claimed |
| US-20220388932-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2022-12-08 | — | — | US | claimed |
| US-20090086131-A1 | LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2009-04-02 | — | — | US | claimed |
| EP-1648862-A2 | SUBSTITUTED ARYLTHIOUREA DERIVATIVES USEFUL AS INHIBITORS OF VIRAL REPLICATION | Achillion Pharmaceuticals, Inc. (US) | 2006-04-26 | — | — | EP | claimed |
| WO-2005007601-A2 | SUBSTITUTED ARYLTHIOUREA DERIVATIVES USEFUL AS INHIBITORS OF VIRAL REPLICATION | ACHILLION PHARMACEUTICALS, INC. (US) | 2005-01-27 | — | — | WO | claimed |
| US-6217792-B1 | Chiral dopants | MERCK PATENT GMBH (DE) | 2001-04-17 | — | — | US | claimed |
| EP-0408995-B1 | Liquid crystal medium with limited temperature-dependence of the d/p coefficient | MERCK PATENT GMBH (DE) | 1995-11-08 | — | — | EP | claimed |
| US-5139698-A | Achiral liquid crystal compound with doping component | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1992-08-18 | — | — | US | claimed |
| US-5069756-A | Separation of cyclohexane from cyclohexene by azeotropic or extractive distillation | Berg, Lloyd (US) | 1991-12-03 | — | — | US | claimed |
| EP-0408995-A2 | Liquid crystal medium with limited temperature-dependence of the d/p coefficient | MERCK PATENT GmbH (DE) | 1991-01-23 | — | — | EP | claimed |
| US-4661594-A | PHOTODEGRADATION INHIBITION | CIBA-GEIGY CORPORATION (US) | 1987-04-28 | — | — | US | claimed |
| US-4017627-A | 7,8-Disubstituted-5-acetylquinolines and antimicrobial compositions containing them | CIBA-GEIGY CORPORATION (US) | 1977-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220388932-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CBR3, CBR1, ADH1C | KDM1A 2002/4885MAPT 2338/4885HSD11B1 355/4885 |
| US-20240043360-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CBR3, CBR1, ADH1C | KDM1A 2002/4885MAPT 2338/4885HSD11B1 355/4885 |
| US-20240217905-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CBR3, CBR1, ADH1C | KDM1A 2002/4885MAPT 2338/4885HSD11B1 355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.